首页|老年高血压相关基因多态性与厄贝沙坦降压疗效的相关性研究

老年高血压相关基因多态性与厄贝沙坦降压疗效的相关性研究

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
  • 维普
目的 探讨老年高血压相关基因多态性对厄贝沙坦降压作用的影响.方法 选取150例轻、中度老年高血压患者,均给予厄贝沙坦治疗8 w,在临床观察疗效的同时,采用PCR-RFLP技术对患者ACE基因I/D多态性、AGT基因M235T多态性和AT1R基因A1166C多态性进行检测.结果 与携带ACE基因II基因型的老年高血压患者比较,携带ID和DD基因型的患者服药后血压下降幅度明显增大,差异具有统计学意义(P<0.05);AGT基因和AT1R基因多态性各基因型之间血压下降幅度差异均无统计学意义.结论 ACE基因I/D多态性与老年高血压患者服用厄贝沙坦后的血压下降幅度有相关性.
Relationships between related gene polymorphisms and antihypertensive effect of irbesartan in the senile hypertensive patients
Objective To investigate the effects of related gene polymorphisms on the antihypertensive effect of irbesartan in the senile hypertensive patients. Methods 150 senile hypertensive patients with mild or moderate hypertension were treated with irbesartan for 8 weeks. At the same time, the ACE gene I/D polymorphism, AGT gene M235T polymorphism and AT1R gene A1166C polymorphism were detected by PCR-RFLP. Results Compared with senile hypertensive patients with ACE II genotype, patients with ID and DD genotype showed a greater reduction in blood pressure after taking the medication and the difference was statistically significant (P<0.05). However, the AGT gene and AT1R gene polymorphisms were not related to the the reduction of blood pressure. Conclusions ACE gene I/D polymorphism was related to the reduction of blood pressure after taking irbesartan in the senile hypertensive patients.

senile hypertensionACE geneAGT geneAT1R geneirbesartan

皇甫卫忠、常福厚、高瑞英、白图雅、席建军

展开 >

内蒙古医科大学附属医院 老年病科,内蒙古 呼和浩特 010050

内蒙古医科大学 药学院,内蒙古呼和浩特,010010

老年高血压 ACE基因 AGT基因 AT1R基因 厄贝沙坦

内蒙古自治区卫生和计划生育委员会项目内蒙古医科大学科技百万工程项目内蒙古自治区自然科学基金内蒙古自治区自然科学基金

201303056YKD2014KJBW0062016MSLH08202015MS08107

2017

10.3969/j.issn.1005-1678.2017.11.012

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN：1005-1678
年,卷(期)：2017.37(11)
  • 5